VFX.AX up 27.55% pre-market ASX 24 Jan 2026: Visionflex Fpo A$0.125, monitor
VFX.AX stock led pre-market movers on the ASX on 24 Jan 2026 after Visionflex Fpo (VFX.AX) climbed 27.55% to A$0.125 in early trade. The jump followed a low open at A$0.105 and lifted the intraday high to A$0.125, on volume of 23,818 shares versus a 50-day average of 56,097. This snapshot ties price action to company fundamentals and short-term model forecasts to help traders assess momentum on the ASX in Australia.
VFX.AX stock: pre-market price action and drivers
Visionflex Fpo (VFX.AX) is the top pre-market gainer on the ASX with a 27.55% one-day rise to A$0.125. Volume was 23,818 shares, below the daily average of 56,097, indicating a price pop with limited follow-through so far.
Fundamentals and valuation for VFX.AX stock
Visionflex reports a market capitalisation of approximately A$10.82M and 86,526,271 shares outstanding. Trailing metrics show EPS -0.05 and PE -2.50, with a price-to-sales ratio of 2.32 and price averages at A$0.09916 (50-day) and A$0.11144 (200-day). These figures highlight a small-cap healthcare services company with negative earnings and stretched valuation ratios versus sector peers.
Technicals and trading signals for VFX.AX stock
Short-term technicals show an ADX of 71.43, signalling a strong trend, while relative volume sits at 0.42. The 50-day average price of A$0.09916 and the intraday high of A$0.125 offer immediate reference points for stop and target levels for active traders.
Meyka AI grade and model forecast for VFX.AX stock
Meyka AI rates VFX.AX with a score out of 100: the model assigns a score of 62.64 (Grade B) and suggests HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly A$0.13 and quarterly A$0.47; compared with the current price of A$0.125, the monthly figure implies +4.00% upside and the quarterly figure implies +276.00% upside. Forecasts are model-based projections and not guarantees.
Risks, liquidity and sector context for VFX.AX stock
Key risks include negative free cash flow per share (-0.05), weak current ratio (0.88) and negative margins, reflecting operational stress in the Healthcare information services industry. Liquidity is limited: average daily volume is 56,097 and recent volume was 23,818, which can magnify price swings on the ASX. Healthcare sector performance is muted year-to-date versus broader markets, which increases sector-specific sensitivity to news.
Short-term outlook and price targets for VFX.AX stock
For traders, a tactical target near A$0.20 flags a first resistance zone, with a more ambitious 12-month scenario around A$0.50 if revenue recovers and margins improve. Support sits near recent lows at A$0.05 and the 200-day average A$0.11144; manage position size because volatility and limited liquidity raise execution risk.
Final Thoughts
VFX.AX stock is a pre-market top gainer on the ASX on 24 Jan 2026 after a 27.55% spike to A$0.125, but the move sits on below-average volume of 23,818 shares. Fundamentals show negative EPS (-0.05) and constrained liquidity, while technicals indicate a strong short-term trend (ADX 71.43). Meyka AI’s grading (Score 62.64, Grade B, suggestion HOLD) balances small-cap risks with upside scenarios; the model projects A$0.13 monthly and A$0.47 quarterly forecasts, implying +4.00% and +276.00% moves versus the current A$0.125 price. Use tight risk controls, watch follow-through volume, and verify any company updates on the Visionflex website before trading. For more real-time metrics and the company profile visit our Meyka stock page and the company site for filings and product news: Meyka VFX.AX stock page and Visionflex Group. Forecasts are model-based projections and not guarantees.
FAQs
Why did VFX.AX stock jump pre-market today?
VFX.AX stock rose 27.55% pre-market on 24 Jan 2026 on a short squeeze and renewed buying interest; volume was 23,818, below average. The move appears driven by momentum rather than fresh earnings or a major corporate announcement.
What is Meyka AI’s view on VFX.AX stock?
Meyka AI rates VFX.AX 62.64/100 (Grade B) with a HOLD suggestion. The model notes small-cap volatility, negative EPS, but potential upside per short-term forecasts. This is informational, not investment advice.
What are realistic price targets for VFX.AX stock?
Near-term tactical resistance is around A$0.20; a bullish medium-term scenario points to A$0.50 if revenue and margins recover. Use risk controls because liquidity is low and fundamentals remain weak.
Where can I check official Visionflex updates for VFX.AX stock?
Check the company website for filings and announcements at Visionflex Group and track market data on our Meyka page at Meyka VFX.AX stock page.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
